The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Harmony Biosciences Holdings Inc shares valued at $121,210,000 were sold by Valor IV Pharma Holdings, LLC on Nov 01 ’24. At $30.30 per share, Valor IV Pharma Holdings, LLC sold 4,000,000 shares. The insider’s holdings dropped to 7,218,033 shares worth approximately $244.26 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Valor IV Pharma Holdings, LLC sold 600,000 shares, netting a total of over 18,181,500 in proceeds. Following the sale of shares at $30.30 each, the insider now holds 6,618,033 shares.
Before that, Marshman Fund Trust II had sold 4,000,000 shares from its account. In a trade valued at $121,210,000, the 10% Owner traded Harmony Biosciences Holdings Inc shares for $30.30 each. Upon closing the transaction, the insider’s holdings decreased to 4,000,000 shares, worth approximately $225.07 million.
Analysts at UBS started covering the stock with ‘”a Buy”‘ outlook in a report released in early September. As of June 21, 2024, Citigroup has initiated its “Buy” rating for HRMY. Earlier on January 02, 2024, BofA Securities downgraded its rating. Their new recommendation was “an Underperform” for HRMY stock which previously was a “a Neutral”.
Analyzing HRMY Stock Performance
During the last five days, there has been a drop of approximately -1.31%. Over the course of the year, Harmony Biosciences Holdings Inc shares have jumped approximately 4.77%. Shares of the company reached a 52-week high of $41.61 on 10/29/24 and a 52-week low of $28.14 on 04/25/24. A 50-day SMA is recorded $36.08, while a 200-day SMA reached $32.92. Nevertheless, trading volume fell to 0.53 million shares from 0.91 million shares the previous day.
Support And Resistance Levels for Harmony Biosciences Holdings Inc (HRMY)
According to the 24-hour chart, there is a support level at 33.24, which, if violated, would cause prices to drop to 32.65. In the upper region, resistance lies at 34.98. The next price resistance is at 36.13. RSI (Relative Strength Index) is 45.83 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.13, which suggests the price will decrease in the coming days. Percent R is at 73.37%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
